The risk for those outcomes, as well as for heart attack, “was at least two to three times higher in patients with a ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about ...

A Canadian study highlights the elevated risks of heart failure and arrhythmia in older adults hospitalized for RSV, even ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

RSV primarily affects children and older adults, and can lead to severe illness or death. Severe illness from respiratory syncytial virus (RSV) can be prevented by administration of prophylactic ...